Sign Up to like & get
recommendations!
0
Published in 2020 at "Inflammation"
DOI: 10.1007/s10753-020-01281-2
Abstract: Gefitinib (Iressa), is a selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), used in the targeted treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC). Skin toxicity is the major adverse…
read more here.
Keywords:
gefitinib induced;
gefitinib;
macrophage infiltration;
cutaneous toxicities ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Anti-Cancer Drugs"
DOI: 10.1097/cad.0000000000000622
Abstract: Gefitinib is an oral tyrosine kinase inhibitor targeting the epidermal growth factor receptor (EGFR) for non-small-cell lung cancer with EGFR mutations. Although a few studies have analyzed the causes of gefitinib-induced hepatotoxicity, research focusing on…
read more here.
Keywords:
gefitinib induced;
induced hepatotoxicity;
time;
hepatotoxicity ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/10781552221076755
Abstract: Introduction: Pemphigus Vulgaris is a rare, noncommunicable, non-hereditary fatal autoimmune dermatological manifestation in which a painful blister initiates from the oral cavity. PRIDE complex stands for Papulopustules or paronychia, regulatory abnormality of hair and nails,…
read more here.
Keywords:
pemphigus vulgaris;
pride complex;
patient;
gefitinib induced ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.15_suppl.e21046
Abstract: e21046 Background: Gefitinib-induced diarrhea can be severe, if not properly handled, and can result in severe dose reductions and treatment interruptions or discontinuation. However, the mechanism of gefitinib-induced diarrhea remains unclear. STAT6 promotes disruption of…
read more here.
Keywords:
stat6 rs167769;
gefitinib;
gefitinib induced;
induced diarrhea ... See more keywords